Detection of cytokeratin18 and cytokeratin19 gene expression in blood and tumor tissue of nasopharyngeal carcinoma patients by RT-PCR
-
摘要: 目的:通过检测CK18和CK19在鼻咽癌患者外周血细胞和癌组织细胞中的表达情况,判断其是否可以作为鼻咽癌的肿瘤标志物辅助诊断鼻咽癌。方法:分别提取45例鼻咽癌患者的外周血样本中的有核细胞和癌组织细胞中的mRNA,逆转为cDNA,设计CK18、CK19和GAPDH引物进行RT-PCR,检测其表达情况。结果:在不同性别、年龄以及转移与否的鼻咽癌患者癌组织细胞中CK18和CK19 基因的表达的均差异无统计学意义(P>0.05),而在不同病理分期的鼻咽癌患者癌组织细胞中,CK18和CK19基因表达随着恶性程度的增高而增高,且均差异有统计学意义(P<0.05);在对鼻咽癌患者的外周血中的CK18和CK19 基因检出率结果显示,CK18的检出率为64%,CK19的检出率75%,年龄大于60岁的患者检出率高于年龄小于60岁的,随着病理检测其恶性程度的增高,CK18和CK19的检出率也相应增高,鼻咽癌转移的患者血液中CK18和CK19的检出率远高于非转移患者。结论:CK18和CK19是可能有潜力作为鼻咽癌诊断的肿瘤标志物。Abstract: Objective: To measure the expression of CK18 and CK19 in the cells from peripheral blood and tumor tissue of the nasopharyngeal carcinoma patients,to test whether CK 18 and CK 19 could be biomarkers of nasopharyngeal carcinoma fordiagnosis.Method: The mRNA was extracted from the blood and carcinoma tissue of nasopharyngeal carcinoma and was reversed transcription to cDNA. The 3 pairs primers were designed for RT-PCR and the fold value was calculated to evaluated expression by △CT. Result: There are no statistical differences between the CK18 and CK19 gene expression and the gender, age and metastasis in tumor tissue of 45 nasopharyngeal carcinoma patients (P>0.05). There are significant differences among 3 pathological stages and 2 genes expressed increase as the grade malignancy (P<0.05).The detecting of the 2 genes expression from blood cells shows that CK18 and CK19 had a high positive ratio 64% and 75% respectively. Meanwhile this method showed a same detection characteristic in tumor and blood, the positive rate of CK18 and CK19 genes in metastasis is higher than non-metastasis. The results showed CK18 has a high specificity and CK19 has a high sensitivity for prognosis and all relapsed cases are associated with the expression of CK18 and CK19.Conclusion: CK18 and CK19 may be used as biomarkers of nasopharyngeal carcinoma for diagnosis.
-
[1] 徐国镇,唐平章,罗京伟.加强以放射治疗为主的鼻咽癌综合治疗研究[J].中华耳鼻咽喉头颈外科杂志,2012,47(3):177-179.
[2] 韩彬彬,魏葆珺,冯莎娜,等.细胞角蛋白18在胃癌化疗疗效评价中临床意义[J].中华实用诊断与治疗杂志,2014,28(2):119-121.
[3] 杨士军,陆卫平,鲍艳梅,等.血清CK18及CA72-4水平在胃癌诊治中的临床价值[J].国际检验医学杂志,2012, 33(13):1593-1594.
[4] 王永斌,马世兴,黄燕妮,等.直肠癌患者血清CK18、CA19-9检测的临床价值[J].放射免疫学杂志,2012, 25(2):151-151.
[5] 朱栋麟,沈荣明,刘晓强,等.CK7、CK18、CK5/6及P63在不同类型肺癌组织中的表达分析[J].中国实用医药,2014, 9(5):1-3.
[6] 朱正,胡学锋,许瑞环,等.鼻咽癌患者外周血中CK 20 mRNA的表达及其临床意义[J].国外医学临床生物化学与检验学,2005,26(7):401-403.
[7] 郭英,黄培林,王景美,等.CK19、CK20 mRNA在上皮性恶性肿瘤患者外周血中的表达及其意义[J].东南大学学报,2003,22(1):9-12.
[8] 贾志凌,杨永昌,刘畅,等.细胞角蛋白18及19与肿瘤标志物联合检测对恶性肿瘤的诊断价值[J].中华实用诊断与治疗杂志,2013, 27(11):1089-1091.
[9] BASTAWISY A E, AZZOUNY M E, MOHAMMED G, et al.Serum cytokeratin 19 fragment in advanced lung cancer:could we eventually have a serum tumor marker[J].Ecancermedicalscience, 2014,8:394-394.
[10] 杜好信,朱武凌,杨献军,等.外周血中CK18mRNA检测对食管癌微转移的诊断意义[J].中国综合临床,2005,121(7):621-623.
计量
- 文章访问数: 68
- PDF下载数: 57
- 施引文献: 0